These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 26454679)

  • 1. Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy?
    Maxwell JE; Sherman SK; O'Dorisio TM; Bellizzi AM; Howe JR
    Surgery; 2016 Jan; 159(1):320-33. PubMed ID: 26454679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs).
    Scott AT; Breheny PJ; Keck KJ; Bellizzi AM; Dillon JS; O'Dorisio TM; Howe JR
    Surgery; 2019 Jan; 165(1):166-175. PubMed ID: 30343949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases.
    Chan DL; Dixon M; Law CHL; Koujanian S; Beyfuss KA; Singh S; Myrehaug S; Hallet J
    Ann Surg Oncol; 2018 Jun; 25(6):1768-1774. PubMed ID: 29560571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small intestinal neuroendocrine tumors with liver metastases and resection of the primary: Prognostic factors for decision making.
    Bertani E; Falconi M; Grana C; Botteri E; Chiappa A; Misitano P; Spada F; Ravizza D; Bazolli B; Fazio N
    Int J Surg; 2015 Aug; 20():58-64. PubMed ID: 26074290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms.
    Chakedis J; Beal EW; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha FG; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Marincola-Smith P; Cho C; Beems M; Pawlik TM; Maithel SK; Schmidt CR; Dillhoff M
    J Gastrointest Surg; 2019 Jan; 23(1):122-134. PubMed ID: 30334178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of Surgical Cytoreduction in Patients with Small Intestinal Neuroendocrine Tumors Metastatic to the Liver and Peritoneum.
    Gudmundsdottir H; Fogliati A; Grotz TE; Thiels CA; Warner SG; Smoot RL; Truty MJ; Kendrick ML; Nagorney DM; Halfdanarson TR; Cleary SP; Starlinger P
    Ann Surg Oncol; 2024 Aug; 31(8):5370-5376. PubMed ID: 38689169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of cytoreductive operations for peritoneal carcinomatosis with or without liver cytoreduction in patients with small bowel neuroendocrine tumors.
    Wonn SM; Limbach KE; Pommier SJ; Ratzlaff AN; Leon EJ; McCully BH; Pommier RF
    Surgery; 2021 Jan; 169(1):168-174. PubMed ID: 32473829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded criteria for debulking of liver metastasis also apply to pancreatic neuroendocrine tumors.
    Morgan RE; Pommier SJ; Pommier RF
    Surgery; 2018 Jan; 163(1):218-225. PubMed ID: 29103583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Treatment of Small Bowel Neuroendocrine Tumors.
    Farley HA; Pommier RF
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):49-61. PubMed ID: 26614368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target.
    Gamboa AC; Ethun CG; Postlewait LM; Lopez-Aguiar AG; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Kooby DA; Staley CA; Cardona K; Maithel SK
    Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Simultaneous Resection of Small Bowel Neuroendocrine Tumors with Synchronous Liver Metastases.
    Addeo P; Bertin JB; Imperiale A; Averous G; Terrone A; Goichot B; Bachellier P
    World J Surg; 2020 Jul; 44(7):2377-2384. PubMed ID: 32179974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of extrahepatic disease among patients undergoing liver-directed therapy for neuroendocrine liver metastasis.
    Ejaz A; Reames BN; Maithel S; Poultsides GA; Bauer TW; Fields RC; Weiss M; Marques HP; Aldrighetti L; Pawlik TM
    J Surg Oncol; 2017 Dec; 116(7):841-847. PubMed ID: 28650564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical management of neuroendocrine tumors.
    Tamburrino D; Spoletini G; Partelli S; Muffatti F; Adamenko O; Crippa S; Falconi M
    Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):93-102. PubMed ID: 26971846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GEP-NETS update: a review on surgery of gastro-entero-pancreatic neuroendocrine tumors.
    Partelli S; Maurizi A; Tamburrino D; Baldoni A; Polenta V; Crippa S; Falconi M
    Eur J Endocrinol; 2014 Oct; 171(4):R153-62. PubMed ID: 24920289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study.
    Sham JG; Ejaz A; Gage MM; Bagante F; Reames BN; Maithel S; Poultsides GA; Bauer TW; Fields RC; Weiss MJ; Marques HP; Aldrighetti L; Pawlik TM; He J
    J Gastrointest Surg; 2019 Mar; 23(3):484-491. PubMed ID: 29980977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery for GEP-NETs.
    Knigge U; Hansen CP
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):819-31. PubMed ID: 23582921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors influencing survival in small bowel neuroendocrine tumor with liver metastases.
    Manguso N; Nissen N; Hendifar A; Harit A; Mirocha J; Friedman M; Lipshutz HG; Amersi F
    J Surg Oncol; 2019 Nov; 120(6):926-931. PubMed ID: 31396982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive Surgical Approach to the Management of Neuroendocrine Tumors: A Report of 1,000 Surgical Cytoreductions by a Single Institution.
    Woltering EA; Voros BA; Beyer DT; Wang YZ; Thiagarajan R; Ryan P; Wright A; Ramirez RA; Ricks MJ; Boudreaux JP
    J Am Coll Surg; 2017 Apr; 224(4):434-447. PubMed ID: 28088602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of imaging in the preoperative staging of small bowel neuroendocrine tumors.
    Chambers AJ; Pasieka JL; Dixon E; Rorstad O
    J Am Coll Surg; 2010 Nov; 211(5):620-7. PubMed ID: 21035044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Resection of Primary Midgut Neuroendocrine Tumors in Patients with Unresectable Metastatic Liver Disease Justified? A Systematic Review and Meta-Analysis.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Kostakis ID; Moris D; Schizas D; Cloyd JM; Pawlik TM
    J Gastrointest Surg; 2019 May; 23(5):1044-1054. PubMed ID: 30671800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.